COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,580 Articles (22,415 medRxiv, 8,165 bioRxiv)

Most recent first Previous |  Page 2430: Articles 24291-24300  | Next

Clinical Features of Hemodialysis (HD) patients confirmed with Coronavirus Disease 2019 (COVID-19): a Retrospective Case-Control Study
Wang, X., Zhou, H., Xiao, X., Tan, X., Zhang, X., He, Y., Li, J., Yang, G., Li, M., Liu, D., Han, S., Kuang, H.
10.1101/2020.07.06.20147827 — Posted: 2020-07-10
Human angiotensin-converting enzyme 2 transgenic mice infected with SARS-CoV-2 develop severe and fatal respiratory disease
Joseph W. Golden, Curtis R. Cline, Xiankun Zeng, Aura R. Garrison, Brian D. Carey, Eric M. Mucker, Lauren E. White, Joshua D. Shamblin, Rebecca L. Brocato, Jun Liu, April M. Babka, Hypaitia B. Rauch, Jeffrey M. Smith, Bradley S. Hollidge, Collin Fitzpatrick, Catherine V. Badger, Jay W. Hooper
10.1101/2020.07.09.195230 — Posted: 2020-07-09
A single-dose live-attenuated YF17D-vectored SARS-CoV2 vaccine candidate
Lorena Sanchez Felipe, Thomas Vercruysse, Sapna Sharma, Ji Ma, Viktor Lemmens, Dominique van Looveren, Mahadesh Prasad Arkalagud Javarappa, Robbert Boudewijns, Bert Malengier-Devlies, Suzanne F. Kaptein, Laurens Liesenborghs, Carolien De Keyzer, Lindsey Bervoets, Madina Rasulova, Laura Seldeslachts, Sander Jansen, Michael Bright Yakass, Osbourne Quaye, Li-Hsin Li, Xin Zhang, Sebastiaan ter Horst, Niraj Mishra, Lotte Coelmont, Christopher Cawthorne, Koen Van Laere, Ghislain Opdenakker, Greetje Van de Velde, Birgit Weynand, Dirk E. Teuwen, Patrick Matthys, Johan Neyts, Hendrik Jan Thibaut, Kai D
10.1101/2020.07.08.193045 — Posted: 2020-07-09
Molecular architecture of the SARS-CoV-2 virus
Hangping Yao, Yutong Song, Yong Chen, Nanping Wu, Jialu Xu, Chujie Sun, Jiaxing Zhang, Tianhao Weng, Zheyuan Zhang, Zhigang Wu, Linfang Cheng, Danrong Shi, Xiangyun Lu, Jianlin Lei, Max Crispin, Yigong Shi, Lanjuan Li, Sai Li
10.1101/2020.07.08.192104 — Posted: 2020-07-09
Dual nature of human ACE2 glycosylation in binding to SARS-CoV-2 spike
Ahmad Reza Mehdipour, Gerhard Hummer
10.1101/2020.07.09.193680 — Posted: 2020-07-09
Screening and testing for a suitable untransfected cell line for SARS-CoV-2 studies
Claudia Pommerenke, Ulfert Rand, Cord C. Uphoff, Stefan Nagel, Margarete Zaborski, Vivian Hauer, Maren Kaufmann, Corinna Meyer, Sabine A. Denkmann, Peggy Riese, Kathrin Eschke, Yeonsu Kim, Zeljka Macak Safranko, Ivan-Christian Kurolt, Alemka Markotic, Linda Brunotte, Stephan Ludwig, Luka Cicin-Sain, Laura Steenpaß
10.1101/2020.07.09.195040 — Posted: 2020-07-09
Air and surface contamination in non-health care settings among 641 environmental specimens of 39 COVID-19 cases
Lei Luo [PhD], Dan Liu [PhD], Hao Zhang [MSc], Zhihao Li [PhD], Ruonan Zhen [MSc], Xiru Zhang [PhD], Huaping Xie [MSc], Weiqi Song [MSc], Jie Liu [MSc], Qingmei Huang [MSc], Jingwen Liu [MSc], Xingfen Yang [PhD], Zongqiu Chen [PhD], Chen Mao [PhD]
10.1101/2020.07.09.195008 — Posted: 2020-07-09
Comprehensive variant and haplotype landscapes of 50,500 global SARS-CoV-2 isolates and accelerating accumulation of country-private variant profiles
Lishuang Shen, Jennifer Dien Bard, Jaclyn A. Biegel, Alexander R. Judkins, Xiaowu Gai
10.1101/2020.07.09.193722 — Posted: 2020-07-09
Structures of potent and convergent neutralizing antibodies bound to the SARS-CoV-2 spike unveil a unique epitope responsible for exceptional potency
Shuo Du, Yunlong Cao, Qinyu Zhu, Guopeng Wang, Xiaoxia Du, Runsheng He, Hua Xu, Yinghui Zheng, Bo Wang, Yali Bai, Chenggong Ji, Ayijiang Yisimayi, Qisheng Wang, Ning Gao, X. Sunney Xie, Xiao-dong Su, Junyu Xiao
10.1101/2020.07.09.195263 — Posted: 2020-07-09 Discussion: Onsite
Assessment of SARS-CoV-2 Specific CD4(+) and CD8 (+) T Cell Responses Using MHC Class I and II Tetramers
Yuri Poluektov, Pirouz Daftarian, Marc C. Delcommenne
10.1101/2020.07.08.194209 — Posted: 2020-07-09

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).